BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 20, 2019
View Archived Issues
Fibrosis in the lung
Read More
New preclinical model of fibrosis
Read More
AKS-130 as a novel long-acting insulin for cancer therapy
Read More
New small molecule VMY- BC-1 shows promise in vitro for TNBC
Read More
Phase I data for HQP-1351 in patients with TKI-resistant CML
Read More
Final phase II data for LCL-161 in patients with myelofibrosis
Read More
Gamida Cell presents phase I data for cellular therapy using GDA-201
Read More
Topline data presented from E.U. phase III study of Wynzora Cream for psoriasis vulgaris
Read More
Results from the first patient cohort of INSIGHT-004 phase I study
Read More
First patient enrolled in phase III GUARD study of ADX-2191 for prevention of PVR
Read More
Embera NeuroTherapeutics receives funding to advance EMB-001 into phase II studies
Read More
NexImmune receives IND clearance for phase I/II study of NEXI-002 in multiple myeloma
Read More
Spravato nasal spray approved in Europe
Read More
New plasma biomarkers found for amyotrophic lateral sclerosis
Read More
Scientists report insights into the mechanics, literally, of IPF
Read More
Crinetics Pharmaceuticals describes new melanocortin MC2 receptor antagonists
Read More
AC Immune discovers microtubule-associated protein tau aggregation inhibitors
Read More
New adenosine A2A receptor antagonists identified at Evotec, Ex Scientia
Read More
Jiangsu Vcare Pharmatech patents neurotrophic tyrosine kinase receptor inhibitors
Read More
Roche describes new Toll-like receptor 7/8/9 antagonists
Read More
Imeglimin completes pivotal phase III program for type 2 diabetes in Japan
Read More
Bone Therapeutics submits CTA for pivotal study of JTA-004 for knee osteoarthritis
Read More
Axovant reports preliminary findings from expanded access treatment with AXO-AAV-GM1
Read More
Cullinan Oncology announces phase I/IIa trials of VK-2019 and CLN-081
Read More
FDA approves Ervebo for prevention of Ebola virus disease
Read More